Anti-tumour necrosis factor therapy in Crohn's disease: where are we now? - Wikidata - wikimedia - TriplyDB

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

http://www.wikidata.org/entity/Q35594912

about

The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.

P2860

Q39032637-14F1B119-B163-46B3-AA05-2C4C61CFC540

P2860

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

http://www.wikidata.org/entity/Q35594912

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@ast

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@en

type

label

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@ast

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@en

prefLabel

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@ast

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@en

P1433

Q35594912-5B1652A8-E929-4610-9995-5ECC0EF7D04D

P1476

Q35594912-D6801F25-6979-4786-89D0-4F25947D24C2

P2093

Q35594912-C27D05BF-96A7-44F6-8581-F59A712D02E7

P2860

Q35594912-6C7ACC41-26DF-4AC1-8C64-5306939E7523

Q35594912-B3DEECD6-9164-4F86-8285-3B58261C1E60

Q35594912-B82DC1E4-3943-426E-90A7-33FAD1CC3931

Q35594912-F30954B3-056F-41DA-BB57-5BB46505D1A5

Q35594912-F74016A9-4709-44CC-A458-4EA89B3804F9

Q35594912-FB924DA3-7954-479A-828D-F75400FA9CB5

P304

Q35594912-5440F9D2-E02E-4E38-9E28-E8528EB4A9BC

P31

Q35594912-4FB36A63-2F00-4BD9-9E8D-DC1098A1B73B

P356

Q35594912-FAC4356B-FF6F-48FA-AA20-60CE91E8D635

P407

Q35594912-A35DB1B4-0C57-4534-B10A-0A49920E36D9

P433

Q35594912-1A880434-9DE3-433F-9A12-1C92B27B3A29

P478

Q35594912-B5D794F1-5BA3-4A42-9BDE-317A3EEB6365

P577

Q35594912-0A9F1472-0996-4D0A-B4C4-94B937D476D2

P5875

Q35594912-EFA7F0F8-4438-4798-81E3-0C881FD7547E

P698

Q35594912-6499F49B-05AB-45DB-A04A-29EC6D4CF4F7

P921

Q35594912-87f66ce3-5133-4077-b66b-f89bcc733383

Q35594912-A891B3C9-A7B5-4AEC-9FD4-4F3C7BD45A16

P932

Q35594912-A5316F70-E71E-43F3-A887-2C9EA1BAF82B

P356

P1433

P1476

Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?

@en

P2093

S J H van Deventer

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance.

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

P304

362-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.51.3.362

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11215045

http://www.w3.org/2001/XMLSchema#string

P698

12171957

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

1773341

http://www.w3.org/2001/XMLSchema#string